Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Putative adverse outcome pathways relevant to neurotoxicity
Visa övriga samt affilieringar
2015 (Engelska)Ingår i: Critical reviews in toxicology, ISSN 1040-8444, E-ISSN 1547-6898, Vol. 45, nr 1, s. 83-91Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

The Adverse Outcome Pathway (AOP) framework provides a template that facilitates understanding of complex biological systems and the pathways of toxicity that result in adverse outcomes (AOs). The AOP starts with an molecular initiating event (MIE) in which a chemical interacts with a biological target(s), followed by a sequential series of KEs, which are cellular, anatomical, and/or functional changes in biological processes, that ultimately result in an AO manifest in individual organisms and populations. It has been developed as a tool for a knowledge-based safety assessment that relies on understanding mechanisms of toxicity, rather than simply observing its adverse outcome. A large number of cellular and molecular processes are known to be crucial to proper development and function of the central (CNS) and peripheral nervous systems (PNS). However, there are relatively few examples of well-documented pathways that include causally linked MIEs and KEs that result in adverse outcomes in the CNS or PNS. As a first step in applying the AOP framework to adverse health outcomes associated with exposure to exogenous neurotoxic substances, the EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) organized a workshop (March 2013, Ispra, Italy) to identify potential AOPs relevant to neurotoxic and developmental neurotoxic outcomes. Although the AOPs outlined during the workshop are not fully described, they could serve as a basis for further, more detailed AOP development and evaluation that could be useful to support human health risk assessment in a variety of ways.

Ort, förlag, år, upplaga, sidor
2015. Vol. 45, nr 1, s. 83-91
Nyckelord [en]
adverse outcome pathway, in vitro testing, key events, molecular initiating event, pathways of neurotoxicity, predictive toxicology
Nationell ämneskategori
Farmakologi och toxikologi Kemi Biologiska vetenskaper
Identifikatorer
URN: urn:nbn:se:su:diva-114260DOI: 10.3109/10408444.2014.981331ISI: 000348199100005PubMedID: 25605028OAI: oai:DiVA.org:su-114260DiVA, id: diva2:798916
Anmärkning

AuthorCount:18;

Tillgänglig från: 2015-03-27 Skapad: 2015-02-25 Senast uppdaterad: 2018-01-11Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Forsby, Anna
Av organisationen
Institutionen för neurokemi
I samma tidskrift
Critical reviews in toxicology
Farmakologi och toxikologiKemiBiologiska vetenskaper

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 236 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf